|
1
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Wang F, Meng W, Wang B and Qiao L:
Helicobacter pylori-induced gastric inflammation and gastric
cancer. Cancer Lett. 345:196–202. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Dong J and Thrift AP: Alcohol, smoking and
risk of oesophago-gastric cancer. Best Pract Res Clin
Gastroenterol. 31:509–517. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Marin JJ, Al-Abdulla R, Lozano E, Briz O,
Bujanda L, Banales JM and Macias RI: Mechanisms of resistance to
chemotherapy in gastric cancer. Anticancer Agents Med Chem.
16:318–334. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Biagioni A, Skalamera I, Peri S, Schiavone
N, Cianchi F, Giommoni E, Magnelli L and Papucci L: Update on
gastric cancer treatments and gene therapies. Cancer Metastasis
Rev. 38:537–548. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Sprecher E, Bergman R, Richard G, Lurie R,
Shalev S, Petronius D, Shalata A, Anbinder Y, Leibu R, Perlman I,
et al: Hypotrichosis with juvenile macular dystrophy is caused by a
mutation in CDH3, encoding P-cadherin. Nat Genet. 29:134–136. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kumara HMCS, Bellini GA, Caballero OL,
Herath SAC, Su T, Ahmed A, Njoh L, Cekic V and Whelan RL:
P-Cadherin (CDH3) is overexpressed in colorectal tumors and has
potential as a serum marker for colorectal cancer monitoring.
Oncoscience. 4:139–147. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Taniuchi K, Nakagawa H, Hosokawa M,
Nakamura T, Eguchi H, Ohigashi H, Ishikawa O, Katagiri T and
Nakamura Y: Overexpressed P-cadherin/CDH3 promotes motility of
pancreatic cancer cells by interacting with p120ctn and activating
rho-family GTPases. Cancer Res. 65:3092–3099. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Liu D, Wu K, Yang Y, Zhu D, Zhang C and
Zhao S: Long noncoding RNA ADAMTS9-AS2 suppresses the progression
of esophageal cancer by mediating CDH3 promoter methylation. Mol
Carcinog. 59:32–44. 2020. View
Article : Google Scholar : PubMed/NCBI
|
|
10
|
Albergaria A, Ribeiro AS, Pinho S,
Milanezi F, Carneiro V, Sousa B, Sousa S, Oliveira C, Machado JC,
Seruca R, et al: ICI 182,780 induces P-cadherin overexpression in
breast cancer cells through chromatin remodelling at the promoter
level: A role for C/EBPbeta in CDH3 gene activation. Hum Mol Genet.
19:2554–2566. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Hibi K, Kitamura YH, Mizukami H, Goto T,
Sakuraba K, Sakata M, Saito M, Ishibashi K, Kigawa G, Nemoto H and
Sanada Y: Frequent CDH3 demethylation in advanced gastric
carcinoma. Anticancer Res. 29:3945–3947. 2009.PubMed/NCBI
|
|
12
|
Imai K, Hirata S, Irie A, Senju S, Ikuta
Y, Yokomine K, Harao M, Inoue M, Tsunoda T, Nakatsuru S, et al:
Identification of a novel tumor-associated antigen, cadherin
3/P-cadherin, as a possible target for immunotherapy of pancreatic,
gastric, and colorectal cancers. Clin Cancer Res. 14:6487–6495.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Hornstein E, Mansfield JH, Yekta S, Hu JK,
Harfe BD, McManus MT, Baskerville S, Bartel DP and Tabin CJ: The
microRNA miR-196 acts upstream of Hoxb8 and Shh in limb
development. Nature. 438:671–674. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Boehm M and Slack FJ: MicroRNA control of
lifespan and metabolism. Cell Cycle. 5:837–840. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Xia J, Li D, Zhu X, Xia W, Qi Z, Li G and
Xu Q: Upregulated miR-665 expression independently predicts poor
prognosis of lung cancer and facilitates tumor cell proliferation,
migration and invasion. Oncol Lett. 19:3578–3586. 2020.PubMed/NCBI
|
|
17
|
Zhou B, Guo W, Sun C, Zhang B and Zheng F:
Linc00462 promotes pancreatic cancer invasiveness through the
miR-665/TGFBR1-TGFBR2/SMAD2/3 pathway. Cell Death Dis. 9:7062018.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhao XG, Hu JY, Tang J, Yi W, Zhang MY,
Deng R, Mai SJ, Weng NQ, Wang RQ, Liu J, et al: miR-665 expression
predicts poor survival and promotes tumor metastasis by targeting
NR4A3 in breast cancer. Cell Death Dis. 10:4792019. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Liu J, Jiang Y, Wan Y, Zhou S, Thapa S and
Cheng W: MicroRNA-665 suppresses the growth and migration of
ovarian cancer cells by targeting HOXA10. Mol Med Rep.
18:2661–2668. 2018.PubMed/NCBI
|
|
20
|
Zhang M, Wang S, Yi A and Qiao Y:
microRNA-665 is down-regulated in gastric cancer and inhibits
proliferation, invasion, and EMT by targeting PPP2R2A. Cell Biochem
Funct. 38:409–418. 2020. View
Article : Google Scholar : PubMed/NCBI
|
|
21
|
Tang H, Long Q, Zhuang K, Yan Y, Han K,
Guo H and Lu X: miR-665 promotes the progression of gastric
adenocarcinoma via elevating FAK activation through targeting SOCS3
and is negatively regulated by lncRNA MEG3. J Cell Physiol.
235:4709–4719. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Li L, Zhu Z, Zhao Y, Zhang Q, Wu X, Miao
B, Cao J and Fei S: FN1, SPARC, and SERPINE1 are highly expressed
and significantly related to a poor prognosis of gastric
adenocarcinoma revealed by microarray and bioinformatics. Sci Rep.
9:78272019. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Jin Y, He J, Du J, Zhang RX, Yao HB and
Shao QS: Overexpression of HS6ST2 is associated with poor prognosis
in patients with gastric cancer. Oncol Lett. 14:6191–6197.
2017.PubMed/NCBI
|
|
24
|
Sobin LH and Compton CC: TNM seventh
edition: What's new, what's changed: Communication from the
International Union Against Cancer and the American Joint Committee
on Cancer. Cancer. 116:5336–5339. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Sierzega M, Kaczor M, Kolodziejczyk P,
Kulig J, Sanak M and Richter P: Evaluation of serum microRNA
biomarkers for gastric cancer based on blood and tissue pools
profiling: The importance of miR-21 and miR-331. Br J Cancer.
117:266–273. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Hsiao TF, Wang CL, Wu YC, Feng HP, Chiu
YC, Lin HY, Liu KJ, Chang GC, Chien KY, Yu JS and Yu CJ:
Integrative omics analysis reveals soluble cadherin-3 as a survival
predictor and an early monitoring marker of EGFR tyrosine kinase
inhibitor therapy in lung cancer. Clin Cancer Res. 26:3220–3229.
2020.PubMed/NCBI
|
|
28
|
Albergaria A, Resende C, Nobre AR, Ribeiro
AS, Sousa B, Machado JC, Seruca R, Paredes J and Schmitt F:
CCAAT/enhancer binding protein β (C/EBPβ) isoforms as
transcriptional regulators of the pro-invasive CDH3/P-cadherin gene
in human breast cancer cells. PLoS One. 8:e557492013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Paredes J, Albergaria A, Oliveira JT,
Jerónimo C, Milanezi F and Schmitt FC: P-cadherin overexpression is
an indicator of clinical outcome in invasive breast carcinomas and
is associated with CDH3 promoter hypomethylation. Clin Cancer Res.
11:5869–5877. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Cao L, Jin H, Zheng Y, Mao Y, Fu Z, Li X
and Dong L: DANCR-mediated microRNA-665 regulates proliferation and
metastasis of cervical cancer through the ERK/SMAD pathway. Cancer
Sci. 110:913–925. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zhou P, Xiong T, Yao L and Yuan J:
MicroRNA-665 promotes the proliferation of ovarian cancer cells by
targeting SRCIN1. Exp Ther Med. 19:1112–1120. 2020.PubMed/NCBI
|
|
32
|
Zhao J, Yang T, Ji J, Zhao F, Li C and Han
X: RHPN1-AS1 promotes cell proliferation and migration via
miR-665/Akt3 in ovarian cancer. Cancer Gene Ther. 28:33–41. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Hu J, Ni G, Mao L, Xue X, Zhang J, Wu W,
Zhang S, Zhao H, Ding L and Wang L: LINC00565 promotes
proliferation and inhibits apoptosis of gastric cancer by targeting
miR-665/AKT3 axis. Onco Targets Ther. 12:7865–7875. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Luo C, Tetteh PW, Merz PR, Dickes E,
Abukiwan A, Hotz-Wagenblatt A, Holland-Cunz S, Sinnberg T, Schittek
B, Schadendorf D, et al: miR-137 inhibits the invasion of melanoma
cells through downregulation of multiple oncogenic target genes. J
Invest Dermatol. 133:768–775. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Lin X, Huang C, Chen Z, Wang H and Zeng Y:
CircRNA_100876 is upregulated in gastric cancer (GC) and promotes
the GC cells' growth, migration and invasion via miR-665/YAP1
signaling. Front Genet. 11:5462752020. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Wu KZ, Zhang CD, Zhang C, Pei JP and Dai
DQ: miR-665 suppresses the epithelial-mesenchymal transition and
progression of gastric cancer by targeting CRIM1. Cancer Manag Res.
12:3489–3501. 2020. View Article : Google Scholar : PubMed/NCBI
|
